From Publishers Weekly
Starred Review. A business fable in the tradition of Who Moved My Cheese?, but more closely akin to Alice in Wonderland, this work from pharmaceuticals CEO Emmens and poet-novelist-journalist Kephart (Flow: The Life and Times of Philadelphia's Schuylkill River) concerns a topsy-turvy organization which should prove oddly familiar for anyone who's worked in a corporate environment. Our heroine, Moira, is a newcomer to the once-respected Zenobia company, now in physical and psychological disrepair. Without signs or helpers, Moira must navigate the bizarre office layout ("countless drab-green cubicles, like so many Brussels sprouts attached to a stalk"), overcome the entrenched mindset ("We excel at the familiar") and find the elusive Room 133A, where she's been summoned to help the flagging enterprise. Emphasizing the power of imagination, innovation, people and possibility, Emmens and Kephart's tale of against-the-system heroism illustrates well the intangible human resources that business-as-usual can squelch. Though it may initially strike serious-minded readers silly, this tale makes an enchanting and worthwhile trip into the rabbit hole of nonsensical corporate culture, drawing out plenty of X-ray insight into the modern workplace. Whimsical line drawings from Sulit complete what could be the most enjoyable, readable business book in recent memory.
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
About the Author
MATTHEW EMMENS is a legendary keynoter and advocate of progressive leadership models in the pharmaceutical industry (as profiled in Forbes magazine), and is CEO of Shire Pharmaceuticals with over 3,000 employees in 15 countries and almost 1.6 billion dollars in revenue annually. BETH KEPHART, a partner in Fusion Communications, is the award-winning author of five books and a regular contributor for the Chicago Tribune, Baltimore Sun and Philadelphia Inquirer. She has won the 2005 Speakeasy Poetry Prize and was a 1998 National Book Award finalist.